Renaissance Technologies »

Perspective Therapeutics shares owned by Renaissance Technologies

Quarter-by-quarter ownership of Perspective Therapeutics shares owned by Renaissance Technologies from 13F filings

Historical chart of Renaissance Technologies investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by Renaissance Technologies

Quarter filed Position value Share count Share price at filing
2024-06-30 $615k 62k 9.97

More positions owned by Renaissance Technologies

Novo-nordisk A S Adr (NVO)
Palantir Technologies Cl A (PLTR)
NVIDIA Corporation (NVDA)
Vertex Pharmaceuticals Incorporated (VRTX)
United Therapeutics Corporation (UTHR)
Verisign (VRSN)
Meta Platforms Cl A (META)
Airbnb Com Cl A (ABNB)
Broadcom (AVGO)
Tesla Motors (TSLA)
Sprouts Fmrs Mkt (SFM)
Franco-Nevada Corporation (FNV)
Apple (AAPL)
Gilead Sciences (GILD)
Exelixis (EXEL)

View all positions for Renaissance Technologies

Top funds holding Perspective Therapeutics

Commodore Capital
Henderson Group
BlackRock
Avidity Partners Management
Vanguard Group
Deerfield Management Company
Octagon Capital Advisors
Marshall Wace
Geode Capital Management
State Street Corporation
Ghost Tree Capital
Paradigm Biocapital Advisors
Sphera Funds Management
Citadel Advisors
Affinity Asset Advisors

View all funds holding Perspective Therapeutics